Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials
- PMID: 25005849
- DOI: 10.1016/j.diabres.2014.06.009
Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials
Abstract
We conducted a meta-analysis to compare the efficacy and safety of repaglinide plus metformin with metformin alone on type 2 diabetes. Twenty-two studies were included in this meta-analysis. Results showed combination therapy was safe and could gain better outcomes in glycemic control. Well-designed studies are required to confirm this conclusion.
Keywords: Combination therapy; Meta-analysis; Metformin; Repaglinide; Type 2 diabetes mellitus.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Comment in
-
Comments on "Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials".Diabetes Res Clin Pract. 2015 Apr;108(1):e1-2. doi: 10.1016/j.diabres.2015.02.004. Epub 2015 Feb 21. Diabetes Res Clin Pract. 2015. PMID: 25747159 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
